PROK2 and central nervous system cancer: Indeed, many recent studies have suggested that circulating Prok2 in serum could serve as a biomarker for various diseases, including neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease [43], low-grade gliomas [44], and Kawasaki disease (a self-limiting inflammatory disorder disease) [45].